Affinity Wealth Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $286K | Hold |
4,097
| – | – | 0.05% | 83 |
|
|
2025
Q1 | $301K | Hold |
4,097
| – | – | 0.06% | 76 |
|
|
2024
Q4 | $268K | Hold |
4,097
| – | – | 0.05% | 85 |
|
|
2024
Q3 | $319K | Sell |
4,097
-6,000
| -59% | -$467K | 0.06% | 81 |
|
|
2024
Q2 | $787K | Hold |
10,097
| – | – | 0.14% | 48 |
|
|
2024
Q1 | $684K | Sell |
10,097
-204
| -2% | -$13.8K | 0.13% | 51 |
|
|
2023
Q4 | $694K | Hold |
10,301
| – | – | 0.14% | 52 |
|
|
2023
Q3 | $698K | Hold |
10,301
| – | – | 0.16% | 54 |
|
|
2023
Q2 | $737K | Buy |
10,301
+204
| +2% | +$14.6K | 0.17% | 55 |
|
|
2023
Q1 | $701K | Hold |
10,097
| – | – | 0.16% | 58 |
|
|
2022
Q4 | $685K | Hold |
10,097
| – | – | 0.16% | 51 |
|
|
2022
Q3 | $554K | Hold |
10,097
| – | – | 0.14% | 55 |
|
|
2022
Q2 | $677K | Hold |
10,097
| – | – | 0.16% | 53 |
|
|
2022
Q1 | $700K | Hold |
10,097
| – | – | 0.14% | 53 |
|
|
2021
Q4 | $602K | Hold |
10,097
| – | – | 0.12% | 60 |
|
|
2021
Q3 | $608K | Buy |
10,097
+4,097
| +68% | +$247K | 0.12% | 67 |
|
|
2021
Q2 | $347K | Hold |
6,000
| – | – | 0.07% | 71 |
|
|
2021
Q1 | $312K | Hold |
6,000
| – | – | 0.06% | 74 |
|
|
2020
Q4 | $315K | Hold |
6,000
| – | – | 0.07% | 71 |
|
|
2020
Q3 | $321K | Hold |
6,000
| – | – | 0.09% | 59 |
|
|
2020
Q2 | $335K | Hold |
6,000
| – | – | 0.42% | 37 |
|
|
2020
Q1 | $311K | Hold |
6,000
| – | – | 0.19% | 39 |
|
|
2019
Q4 | $299K | Hold |
6,000
| – | – | 0.11% | 73 |
|
|
2019
Q3 | $267K | Hold |
6,000
| – | – | 0.11% | 75 |
|
|
2019
Q2 | $248K | Hold |
6,000
| – | – | 0.1% | 87 |
|
|
2019
Q1 | $243K | Hold |
6,000
| – | – | 0.1% | 90 |
|
|
2018
Q4 | $228K | Buy |
+6,000
| New | +$228K | 0.14% | 86 |
|
|
2017
Q3 | $203K | Hold |
6,000
| – | – | 0.12% | 69 |
|
|
2017
Q2 | $204K | Buy |
+6,000
| New | +$204K | 0.13% | 69 |
|